It's time to roll up sleeves for new COVID, flu shots
Yes, you can get your flu and COVID-19 shots at the same time. Don't call them boosters — they're not just another dose of ...
bovnews1h
What’s Fueling Novavax Inc (NVAX) Stock’s 48.65% Gain Above Its 200-Day SMA?
On Friday, Novavax Inc (NVAX) stock saw a modest uptick, ending the day at $13.3 which represents a slight increase of $1.15 or 9.47% from the prior close of $12.15. The stock opened at $12.32 and ...
CNET on MSN21h
Move Over, mRNA: What to Know About the Novavax COVID Vaccine
Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.
Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...
On the hunt for Novavax: Why people are seeking out the 'traditional' COVID vaccine
Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...
Public Opinion4h
It's vaccination season. Here's what you need to know about flu, COVID-19, RSV shots
Getting vaccinated is one of the most effective ways to protect yourself and your loved ones from the flu, COVID-19 and RSV.
Novavax Inc. stock outperforms competitors on strong trading day
Novavax Inc. closed $10.57 below its 52-week high ($23.86), which the company reached on June 6th.
Novavax Inc. stock underperforms Monday when compared to competitors
Novavax Inc. closed $11.06 below its 52-week high ($23.86), which the company achieved on June 6th.